Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Cantor Fitzgerald
Fish and Richardson
Mallinckrodt
Chinese Patent Office
Baxter
Covington
Johnson and Johnson

Generated: December 13, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,521,212

« Back to Dashboard

Which drugs does patent 6,521,212 protect, and when does it expire?

Patent 6,521,212 protects TYVASO and is included in one NDA.

This patent has fifteen patent family members in eleven countries.

Summary for Patent: 6,521,212
Title: Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
Abstract:A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.
Inventor(s): Cloutier; Gilles (Chapel Hill, NC), Crow; James (Chapel Hill, NC), Wade; Michael (Chapel Hill, NC), Parker; Richard E. (Spring Hill, TN), Loyd; James E. (Nashville, TN)
Assignee: United Therapeutics Corporation (Silver Spring, MD)
Application Number:09/525,471
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,521,212
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition; Delivery;

Drugs Protected by US Patent 6,521,212

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
United Therap TYVASO treprostinil SOLUTION;INHALATION 022387-001 Jul 30, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF PULMONARY HYPERTENSION BY INHALATION ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,521,212

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 245979 ➤ Try a Free Trial
Australia 4082700 ➤ Try a Free Trial
Canada 2365890 ➤ Try a Free Trial
China 1196479 ➤ Try a Free Trial
China 1379665 ➤ Try a Free Trial
Germany 60004181 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Cantor Fitzgerald
Teva
McKinsey
Argus Health
McKesson
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.